CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-Germany

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-Germany


  • Products Id :- GDHC0079CHR
  • |
  • Pages: 228
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-Germany

Summary

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-Germany". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Germany. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Germany. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

In 2016, Germany population was approximately at 82.2 million. The German pharmaceutical market is the largest in Europe and the third largest in the world after the US and Japan. The market value increased from EUR37.8 billion ($48.6 billion) in 2009 to EUR52.9 billion ($67.9 billion) in 2016, at a Compound Annual Growth Rate (CAGR) of 4.9%. The market value comprises revenues from drug stores and discount stores, including taxes. The value of the market is expected to reach EUR67.2 billion ($86.3 billion) in 2021. The medical device market was valued at $21.1 billion in 2009 and increased to $27.5 billion in 2016. It is expected to grow at a CAGR of 4.5% from $28.8 billion in 2017 to $34.4 billion in 2021.

These positive trends can primarily be attributed to-

An increasing elderly population in Germany, leading to increases in disease incidence and prevalence as well as higher need for long-term care and medical devices

Increasing awareness in the medical community and the general population regarding early disease detection and diagnosis, leading to higher rates of adoption of treatments and healthcare

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Germany, and includes-

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

Profiles and SWOT analyses of the major players in the pharmaceutical market (Novartis, Sanofi, Bayer, Roche and Pfizer) and profiles and SWOT analyses of the major players in the medical device market (Johnson & Johnson, Medtronic, Baxter International and B.Braun)

An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices

Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure

An overview of the opportunities for and challenges to growth in the German healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to-

Develop business strategies by understanding the trends shaping and driving German healthcare market

Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future

Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors

Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

Identify, understand, and capitalize on the opportunities and challenges in German healthcare market



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 6

2 Executive Summary 9

3 Introduction 14

3.1 GlobalData Report Guidance 14

4 Overview of the Pharmaceutical and Medical Device Markets 15

4.1 Pharmaceutical Market 15

4.1.1 Market Overview 15

4.1.2 Pharmaceutical Imports and Exports 17

4.1.3 Supply Channels 18

4.1.4 Market Segments 21

4.1.5 Overview of Top Five Disease Areas 25

4.1.6 Major Players 28

4.2 Medical Device Market 60

4.2.1 Market Overview 60

4.2.2 Overview of Top Five Segments 62

4.2.3 Major Players 73

4.3 Market Drivers and Barriers 96

4.3.1 Drivers 96

4.3.2 Barriers 97

5 Market Access 100

5.1 Reimbursement and Payer Landscape 100

5.1.1 Overview of Healthcare System 100

5.1.2 Reimbursement Process 101

5.1.3 Overview of Insurance Providers 104

5.1.4 Patient Share in Healthcare Spending 107

5.1.5 Price Trend in Healthcare Services 109

5.1.6 Pricing Policies 110

5.2 Regulatory Landscape 114

5.2.1 Overview of Regulatory Agencies 114

5.2.2 Market Authorization Procedure for Pharmaceutical Products 116

5.2.3 Market Authorization Procedure for Medical Devices 123

5.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 127

5.2.5 Licensing Process for Pharmaceutical Exports and Imports 128

5.2.6 Intellectual Property Rights 129

5.2.7 Clinical Trial Regulations 134

5.2.8 Pharmaceutical Advertising Regulations 136

5.2.9 Pharmacy Regulations 138

5.2.10 Labeling and Packaging Regulations 138

6 Country Analysis 141

6.1 Political Environment 141

6.1.1 Political Structure 141

6.1.2 Analysis of the Current Political Environment 143

6.1.3 Healthcare Policy Initiatives 145

6.2 Economic Landscape 147

6.3 Economic Indicators 150

6.3.1 Gross Domestic Product 150

6.3.2 Gross National Income 153

6.3.3 Inflation 155

6.3.4 Currency Exchange Rate 156

6.3.5 Foreign Direct Investment 158

6.3.6 Foreign Exchange Reserves 159

6.3.7 Trade Balance 159

6.3.8 General Government Structural Balance 161

6.3.9 General Government Net Debt 163

6.3.10 Major Industries 164

6.4 Demographics 165

6.4.1 Population 165

6.4.2 Urban-Rural Share 167

6.4.3 Distribution by Age Group 168

6.4.4 Birth Rate 170

6.4.5 Mortality 171

6.4.6 Causes of Mortality 171

6.4.7 Health Status by Gender and Age 173

6.4.8 Education and Literacy 178

6.4.9 Employment 181

6.4.10 Disease Burden 181

6.5 Healthcare Infrastructure 185

6.5.1 Healthcare Facilities 185

6.5.2 Healthcare Parameters 188

6.5.3 Environmental Health 190

6.5.4 Healthcare Personnel 193

6.6 Healthcare Expenditure 197

6.6.1 Overview 197

6.6.2 Public-Private Sector Share 199

6.6.3 Major Components of Healthcare Spending 199

6.6.4 Spending in Science and Technology Research and Development 201

6.7 Trade Associations 201

6.7.1 The Association of Research Based Pharmaceutical Companies 201

6.7.2 The Federation of Pharmaceutical Manufacture 202

6.7.3 The Federation of Pharmaceutical Industry 202

6.8 Trade Fairs 203

7 Opportunities and Challenges 204

7.1 Opportunities 204

7.2 Challenges 204

8 Appendix 206

8.1 Abbreviations 206

8.2 Bibliography 211

8.3 Research Methodology 226

8.3.1 Coverage 226

8.3.2 Secondary Research 227

8.3.3 Forecasts 227

8.3.4 Expert Panel 228

8.4 Contact Us 228

8.5 Disclaimer 228

1.2 List of Figures

Figure 1: Pharmaceutical Market, Germany, Revenue ($bn), 2009-2021 10

Figure 2: Medical Device Market, Germany, Revenue ($bn), 2009-2021 11

Figure 3: Country Profile, Germany, 2016 13

Figure 4: Pharmaceutical Market, Germany, Revenue ($bn), 2009-2016 16

Figure 5: Pharmaceutical Market, Germany, Revenue Forecast ($bn), 2017-2021 17

Figure 6: Pharmaceutical Market, Germany, Pharmaceutical Imports and Exports ($bn), 2009-2015 18

Figure 7: Pharmaceutical Market, Germany, Supply Channel, 2017 19

Figure 8: Pharmaceutical Market, Germany, Generic Pharmaceutical Market Revenue ($bn), 2008-2016 22

Figure 9: Pharmaceutical Market, Germany, Biological Drugs in Pipeline and Approved, 2009-2015 23

Figure 10: Pharmaceutical Market, Germany, OTC Drug Market Revenue ($bn), 2009-2016 24

Figure 11: Pharmaceutical Market, Germany, Major OTC Drug Classes, Revenue ($m), 2015 25

Figure 12: Pharmaceutical Market, Germany, Major Disease Areas, Total Cost of Illness ($bn), 2008 26

Figure 13: Medical Device Market, Germany, Revenue ($bn), 2009-2016 61

Figure 14: Medical Device Market, Germany, Revenue Forecast ($bn), 2017-2021 62

Figure 15: Medical Device Market, Germany, Revenue by Segment ($bn), 2016 63

Figure 16: Wound Care Management Market, Germany, Revenue ($bn), 2009-2016 64

Figure 17: Wound Care Management Market, Germany, Market Share of Major Players (%), 2012 65

Figure 18: Orthopedic Devices Market, Germany, Revenue ($bn), 2009-2016 66

Figure 19: Orthopedic Devices Market, Germany, Market Share of Major Players (%), 2016 67

Figure 20: Ophthalmic Devices Market, Germany, Revenue ($bn), 2009-2016 68

Figure 21: Ophthalmic Devices Market, Germany, Market Share of Major Players (%), 2015 68

Figure 22: Cardiovascular Devices Market, Germany, Revenue ($bn), 2009-2016 70

Figure 23: Cardiovascular Devices Market, Germany, Market Share of Major Players (%), 2015 71

Figure 24: IVD Market, Germany, Revenue ($bn), 2009-2016 72

Figure 25: IVD Market, Germany, Market Share of Major Companies (%), 2014 72

Figure 26: Medical Device Market, Germany, Revenue of Major Companies ($m), 2012 73

Figure 27: Healthcare Market, Germany, Drivers and Barriers, 2017 99

Figure 28: Market Access, Germany, Roles of Regulatory Bodies, 2017 102

Figure 29: Market Access, Germany, Reimbursement Process, 2017 103

Figure 30: Market Access, Germany, Number of SHI Providers, 2009-2017 105

Figure 31: Market Access, Germany, Out-of-Pocket Expenditure (%), 2009-2015 108

Figure 32: Market Access, Germany, Healthcare Price Index, Annual Change (%), 2009-2016 110

Figure 33: Market Access, Germany, AMNOG Reimbursement Process for Drugs, 2017 114

Figure 34: Market Access, Germany, Organizational Structure of BfArM, 2017 115

Figure 35: Market Access, Germany, Organizational Structure of PEI, 2017 116

Figure 36: Market Access, EU, Centralized Procedure, Market Authorization, Pre-submission Phase, 2017 118

Figure 37: Market Access, EU, Centralized Procedure, Market Authorization, Pre-opinion Phase, 2017 119

Figure 38: Market Access, EU, Centralized Procedure, Market Authorization, Post-opinion Phase, 2017 120

Figure 39: Market Access, EU, Decentralized Procedure, Market Authorization, 2017 121

Figure 40: Market Access, EU, Conformity Assessment of Class I Medical Devices, 2017 124

Figure 41: Market Access, EU, Conformity Assessment of Class IIa Medical Devices, 2017 125

Figure 42: Market Access, EU, Conformity Assessment of Class IIb Medical Devices, 2017 126

Figure 43: Market Access, EU, Conformity Assessment of Class III Medical Devices, 2017 127

Figure 44: Market Access, Germany, Patent Approval Process, 2017 130

Figure 45: Market Access, Germany, Trademark Approval Process, 2017 133

Figure 46: Economic Indicators, Germany, Gross Domestic Product per Capita ($), 2009-2016 150

Figure 47: Economic Indicators, Germany, Gross Domestic Product per Capita Forecast ($), 2017-2021 151

Figure 48: Economic Indicators, Germany, Gross Domestic Product Annual Growth (%), 2009-2016 152

Figure 49: Economic Indicators, Germany, Gross Domestic Product Annual Growth Forecast (%), 2017-2021 153

Figure 50: Economic Indicators, Germany, Gross National Income per Capita ($), 2009-2016 154

Figure 51: Economic Indicators, Germany, Average Consumer Price Index, 2009-2016 155

Figure 52: Economic Indicators, Germany, Average Consumer Price Annual Change (%), 2009-2016 156

Figure 53: Economic Indicators, Germany, Currency Exchange Rate (EUR per $), 2009-2016 157

Figure 54: Economic Indicators, Germany, Foreign Direct Investment ($bn), 2009-2015 158

Figure 55: Economic Indicators, Germany, Foreign Exchange Reserves ($bn), 2009-2016 159

Figure 56: Economic Indicators, Germany, Imports of Goods and Services ($bn), 2009-2016 160

Figure 57: Economic Indicators, Germany, Exports of Goods and Services ($bn), 2009-2016 161

Figure 58: Economic Indicators, Germany, Government Structural Balance ($bn), 2009-2016 162

Figure 59: Economic Indicators, Germany, General Government Net Debt ($bn), 2009-2016 163

Figure 60: Economic Indicators, Germany, Major Industries by Revenue ($bn), 2015 164

Figure 61: Demographics, Germany, Population (million), 2009-2016 165

Figure 62: Demographics, Germany, Population (million), 2017-2021 166

Figure 63: Demographics, Germany, Urban-Rural Population Share (%), 2009-2016 167

Figure 64: Demographics, Germany, Population Distribution by Age Group (%), 2009-2016 168

Figure 65: Demographics, Germany, Population Distribution by Age Group Forecast (%), 2017-2021 169

Figure 66: Demographics, Germany, Births (per 1,000 population), 2009-2016 170

Figure 67: Demographics, Germany, Mortality (per 1,000 population), 2009-2016 171

Figure 68: Demographics, Germany, Major Causes of Mortality, 2015 172

Figure 69: Demographics, Germany, Infant Mortality (per 1,000 live births), 2009-2016 173

Figure 70: Demographics, Germany, Immunization Rate (%), 2009-2016 174

Figure 71: Demographics, Germany, Major Causes of Male Mortality, 2015 175

Figure 72: Demographics, Germany, Major Causes of Female Mortality, 2015 176

Figure 73: Demographics, Germany, Gender Ratio (M/F), 2009-2016 177

Figure 74: Demographics, Germany, Life Expectancy at Birth (years), 2009-2016 178

Figure 75: Demographics, Germany, Highest Level of General Education Completed, Share (%), 2015 179

Figure 76: Demographics, Germany, Vocational Qualification, Share (%), 2015 180

Figure 77: Demographics, Germany, Unemployment Rate (%), 2009-2016 181

Figure 78: Demographics, Germany, Most Frequently Diagnosed Diseases ('000), 2015 182

Figure 79: Demographics, Germany, Disability-Adjusted Life Years by Major Disease ('000), 2012 184

Figure 80: Healthcare Infrastructure, Germany, Number of Hospitals, 2009-2015 185

Figure 81: Healthcare Infrastructure, Germany, Acute Care Hospitals (per 10,000 population), 2009-2015 186

Figure 82: Healthcare Infrastructure, Germany, Diagnostic Equipment (per million population), 2009-2015 187

Figure 83: Healthcare Infrastructure, Germany, Hospital Beds (per 1,000 population), 2009-2015 188

Figure 84: Healthcare Infrastructure, Germany, Acute Care Hospital Beds (per 1,000 population), 2009-2015 189

Figure 85: Healthcare Infrastructure, Germany, Psychiatric Hospital Beds (per 1,000 population), 2009-2015 190

Figure 86: Healthcare Infrastructure, Germany, PM2.5 (g per mP3P), 2009-2015 191

Figure 87: Healthcare Infrastructure, Germany, CO2 Emissions (million metric tons), 2009-2015 192

Figure 88: Healthcare Infrastructure, Germany, Healthcare Personnel ('000), 2009-2015 193

Figure 89: Healthcare Infrastructure, Germany, Physicians (per 1,000 population), 2009-2015 194

Figure 90: Healthcare Infrastructure, Germany, Dentists (per 1,000 population), 2009-2015 195

Figure 91: Healthcare Infrastructure, Germany, Pharmacists (per 1,000 population), 2009-2015 196

Figure 92: Healthcare Infrastructure, Germany, Nurses (per 1,000 population), 2009-2015 197

Figure 93: Healthcare Expenditure, Germany, Healthcare Expenditure as Percentage of GDP (%), 2009-2015 198

Figure 94: Healthcare Expenditure, Germany, Public-Private Share (%), 2009-2015 199

Figure 95: Healthcare Expenditure, Germany, Public-Private Share (%), 2015 200

Figure 96: Healthcare Expenditure, Germany, R&D Expenditure as Percentage of GDP (%), 2009-2015 201

Figure 97: Healthcare Market, Germany, Opportunities and Challenges, 2017 205

1.1 List of Tables

Table 1: Pharmaceutical Market, Germany, Revenue ($bn), 2009-2016 16

Table 2: Pharmaceutical Market, Germany, Revenue Forecast ($bn), 2017-2021 17

Table 3: Pharmaceutical Market, Germany, Pharmaceutical Imports and Exports ($bn), 2009-2015 18

Table 4: Pharmaceutical Market, Germany, Wholesale Mark-up for Proprietary Medicinal Products ($bn), 2017 20

Table 5: Pharmaceutical Market, Germany, Retail Pharmacy Mark-up for Proprietary Medicinal Products ($bn), 2017 21

Table 6: Pharmaceutical Market, Germany, Generic Pharmaceutical Market Revenue ($bn), 2009-2016 22

Table 7: Pharmaceutical Market, Germany, Biological Drugs in Pipeline and Approved, 2009-2015 23

Table 8: Pharmaceutical Market, Germany, OTC Drug Market Revenue ($bn), 2009-2016 24

Table 9: Pharmaceutical Market, Germany, Major OTC Drug Classes, Revenue ($m), 2015 25

Table 10: Pharmaceutical Market, Germany, Major Disease Areas, Total Cost of Illness ($bn), 2008 26

Table 11: Novartis, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2016 29

Table 12: Pharmaceutical Market, Novartis, Planned Filings, 2017-2020 30

Table 13: Sanofi, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2016 36

Table 14: Pharmaceutical Market, Sanofi, Global, Late-stage Pipeline, 2017 37

Table 15: Bayer, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2016 41

Table 16: Pharmaceutical Market, Roche, Global, Revenue ($m) and Annual Growth (%) of Major Products, 2016 46

Table 17: Pharmaceutical Market, Roche, Global, Late-stage Pipeline, 2017 47

Table 18: Pharmaceutical Market, Pfizer, Global, Revenue ($m) and Annual Growth (%) of Major Products, 2016 53

Table 19: Pharmaceutical Market, Pfizer, Global, Late-Stage Pipeline, 2017 53

Table 20: Medical Device Market, Germany, Revenue ($bn), 2009-2016 61

Table 21: Medical Device Market, Germany, Revenue Forecast ($bn), 2017-2021 62

Table 22: Medical Device Market, Germany, Revenue by Segment ($bn), 2016 63

Table 23: Ophthalmic Devices Market, Germany, Revenue ($bn), 2009-2016 64

Table 24: Wound Care Management Market, Germany, Revenue ($m) and Market Share (%) of Major Companies, 2012 65

Table 25: Orthopedic Devices Market, Germany, Revenue ($bn), 2009-2016 66

Table 26: Orthopedic Devices Market, Germany, Revenue ($m) and Market Share (%) of Major Companies, 2016 67

Table 27: Ophthalmic Devices Market, Germany, Revenue ($bn), 2009-2016 68

Table 28: Ophthalmic Devices Market, Germany, Revenue ($m) and Market Share (%) of Major Companies, 2015 69

Table 29: Cardiovascular Devices Market, Germany, Revenue of Major Players ($bn), 2009-2016 70

Table 30: Cardiovascular Devices Market, Germany, Revenue ($m) and Market Share (%) of Major Companies, 2015 71

Table 31: IVD Market, Germany, Revenue ($bn), 2009-2016 72

Table 32: IVD Market, Germany, Revenue ($m) and Market Share (%) of Major Companies, 2014 73

Table 33: Medical Device Market, Germany, Revenue ($m) and Market Share (%) of Major Companies, 2012 74

Table 34: Medical Device Market, Medtronic, Major Products, 2016 80

Table 35: Baxter International, Global, Major Products, 2017 86

Table 36: Market Access, Germany, Number of SHI Providers, 2009-2017 105

Table 37: Market Access, Germany, Out-of-Pocket Expenditure (%), 2009-2015 108

Table 38: Market Access, Germany, Healthcare Price Index, Annual Change (%), 2009-2016 110

Table 39: Market Access, Germany, Early Assessment of Drugs, 2013 113

Table 40: Market Access, Germany, Patent Application Fees, 2017 130

Table 41: Market Access, Germany, Trademark Registration Fees, 2017 132

Table 42: Market Access, Germany, Voluntary Harmonization Procedure, 2017 136

Table 43: Economic Indicators, Germany, Gross Domestic Product per Capita ($), 2009-2016 150

Table 44: Economic Indicators, Germany, Gross Domestic Product per Capita Forecast ($), 2017-2021 151

Table 45: Economic Indicators, Germany, Gross Domestic Product Annual Growth (%), 2009-2016 152

Table 46: Economic Indicators, Germany, Gross Domestic Product Annual Growth Forecast (%), 2017-2021 153

Table 47: Economic Indicators, Germany, Gross National Income per Capita ($), 2009-2016 154

Table 48: Economic Indicators, Germany, Average Consumer Price Index, 2009-2016 155

Table 49: Economic Indicators, Germany, Average Consumer Price Annual Change (%), 2009-2016 156

Table 50: Economic Indicators, Germany, Currency Exchange Rate (EUR per $), 2009-2016 157

Table 51: Economic Indicators, Germany, Foreign Direct Investment ($bn), 2009-2015 158

Table 52: Economic Indicators, Germany, Foreign Exchange Reserves ($bn), 2009-2016 159

Table 53: Economic Indicators, Germany, Imports of Goods and Services ($bn), 2009-2016 160

Table 54: Economic Indicators, Germany, Exports of Goods and Services ($bn), 2009-2016 161

Table 55: Economic Indicators, Germany, Government Structural Balance ($bn), 2009-2016 162

Table 56: Economic Indicators, Germany, General Government Net Debt ($bn), 2009-2016 163

Table 57: Economic Indicators, Germany, Major Industries by Revenue ($bn), 2015 164

Table 58: Demographics, Germany, Population (million), 2009-2016 165

Table 59: Demographics, Germany, Population (million), 2017-2021 166

Table 60: Demographics, Germany, Urban-Rural Population Share (%), 2009-2016 167

Table 61: Demographics, Germany, Population Distribution by Age Group (%), 2009-2016 168

Table 62: Demographics, Germany, Population Distribution by Age Group Forecast (%), 2017-2021 169

Table 63: Demographics, Germany, Births (per 1,000 population), 2009-2016 170

Table 64: Demographics, Germany, Mortality (per 1,000 population), 2009-2016 171

Table 65: Economic Indicators, Germany, Major Causes of Mortality, 2015 172

Table 66: Demographics, Germany, Infant Mortality (per 1,000 live births), 2009-2016 173

Table 67: Demographics, Germany, Immunization Rate (%), 2009-2016 174

Table 68: Demographics, Germany, Major Causes of Male Mortality, 2015 175

Table 69: Demographics, Germany, Major Causes of Female Mortality, 2015 176

Table 70: Demographics, Germany, Gender Ratio (M/F), 2009-2016 177

Table 71: Demographics, Germany, Life Expectancy at Birth (years), 2009-2016 178

Table 72: Demographics, Germany, Highest Level of General Education Completed, Share (%), 2015 179

Table 73: Demographics, Germany, Vocational Qualification, Share (%), 2015 180

Table 74: Demographics, Germany, Unemployment Rate (%), 2009-2016 181

Table 75: Demographics, Germany, Most Frequently Diagnosed Diseases ('000), 2015 183

Table 76: Demographics, Germany, Disability-Adjusted Life Years by Major Disease ('000), 2012 184

Table 77: Healthcare Infrastructure, Germany, Number of Hospitals, 2009-2015 185

Table 78: Healthcare Infrastructure, Germany, Acute Care Hospitals (per 10,000 population), 2009-2015 186

Table 79: Healthcare Infrastructure, Germany, Diagnostic Equipment (per million population), 2009-2015 187

Table 80: Healthcare Infrastructure, Germany, Hospital Beds (per 1,000 population), 2009-2015 188

Table 81: Healthcare Infrastructure, Germany, Acute Care Hospital Beds (per 1,000 population), 2009-2015 189

Table 82: Healthcare Infrastructure, Germany, Psychiatric Hospital Beds (per 1,000 population), 2009-2015 190

Table 83: Healthcare Infrastructure, Germany, PM2.5 (g per mP3P), 2009-2015 191

Table 84: Healthcare Infrastructure, Germany, CO2 Emissions (million metric tons), 2009-2015 192

Table 85: Healthcare Infrastructure, Germany, Healthcare Personnel ('000), 2009-2015 193

Table 86: Healthcare Infrastructure, Germany, Doctors (per 1,000 population), 2009-2015 194

Table 87: Healthcare Infrastructure, Germany, Dentists (per 1,000 population), 2009-2015 195

Table 88: Healthcare Infrastructure, Germany, Pharmacists (per 1,000 population), 2009-2015 196

Table 89: Healthcare Infrastructure, Germany, Nurses (per 1,000 population), 2009-2015 197

Table 90: Healthcare Expenditure, Germany, Healthcare Expenditure as Percentage of GDP (%), 2009-2015 198

Table 91: Healthcare Expenditure, Germany, Public-Private Share (%), 2009-2015 199

Table 92: Healthcare Expenditure, Germany, Public-Private Share (%), 2015 200

Table 93: Healthcare Expenditure, Germany, R&D Expenditure as Percentage of GDP (%), 2009-2015 201

Table 94: Healthcare Expenditure, Germany, Major Healthcare Trade Fairs, 2017 203

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Germany, Pharmaceutical Market, Medical Device Market, Drivers and Barriers, major Players, Regulatory landscape, Reimbursement landscape,Political Landscape, Economic Landscape, Oppurtunities and Challenges

select a license

Single User License
USD 1995 INR 128817
Site License
USD 3990 INR 257634
Corporate User License
USD 5985 INR 386451

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com